Emerging medical therapies for congenital adrenal hyperplasia [version 1; peer review: 4 approved]
Congenital adrenal hyperplasia has traditionally been treated with daily oral doses of glucocorticoids and mineralocorticoid supplements. Such therapy does not precisely replicate the adrenal cortex's circadian pattern. As a consequence, patients are intermittently overtreated or undertreated l...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-04-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-363/v1 |